At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,000 target
Drug / intervention
Urine Drug Testingother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Accuracy of Point of Care (POC) or In-office Urine Drug Testing (Immunoassay) in Chronic Pain Patients: A Prospective Analysis of Immunoassay and Liquid Chromatography Tandem Mass Spectometry (LC/MS/MS)
In Brief
An observational study evaluating Urine Drug Testing for Chronic Pain. Completed, enrolled 1,000 participants.
Detailed Summary
Accuracy of Point of Care (POC) or In-office Urine Drug Testing (Immunoassay) in Chronic Pain Patients: A Prospective Analysis of Immunoassay and Liquid Chromatography Tandem Mass Spectometry (LC/MS/MS)
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain
Countries--
CollaboratorsMillennium Laboratories
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJan 2010
Enrollment StartFeb 2010
Primary CompletionJun 2010
TodayJul 2026
First PostedJan 20, 2010
Enrollment StartFeb 1, 2010
Primary CompletionJun 1, 2010
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 16.4 years ago
Interventions
Urine Drug Testingother
LC/MS/MS Laboratory Evaluation